2003;15: 380 4. 430. Dzavik V, Sleeper LA, Cocke TP, et al. Early revascularization is associated with improved survival in elderly patients with acute myo- cardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828 37. 431. Prasad A, Lennon RJ, Rihal CS, et al. Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J. 2004;147:1066 70. 432. Babaev A, Every NR, Frederick P. Trends in revascularization and mortality in patients with cardiogeneic shock complicating acute myo- cardial infarction. Circulation. 2002;106 Suppl II:364. Abstract. 433. Thiele H, Allam B, Chatellier G, et al. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J. 2010;31:1828 35. 434. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myo- cardial infarction: should we change the guidelines? Eur Heart J. 2009; 30:459 68. 435. Bates ER. Percutaneous coronary intervention for cardiogenic shock. In: Hochman JS, Ohman EM, editors. Cardiogenic Shock. Hoboken, NJ: Wiley-Blackwell; 2009:220 39. 436. Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angio- plasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol. 1998;31:294 300. 437. Chan AW, Chew DP, Bhatt DL, et al. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock compli- cating acute myocardial infarction. Am J Cardiol. 2002;89:132 6. 438. Huang R, Sacks J, Thai H, et al. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65:25 33. 439. Yip HK, Wu CJ, Chang HW, et al. 